Lord Abbett & CO. LLC Trims Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Lord Abbett & CO. LLC trimmed its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 12.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 282,459 shares of the medical equipment provider's stock after selling 39,779 shares during the quarter. Lord Abbett & CO. LLC owned 0.08% of Intuitive Surgical worth $147,432,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Bennett Selby Investments LP boosted its stake in shares of Intuitive Surgical by 3.9% during the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider's stock worth $234,000 after acquiring an additional 17 shares in the last quarter. Onefund LLC increased its stake in Intuitive Surgical by 1.9% during the 4th quarter. Onefund LLC now owns 947 shares of the medical equipment provider's stock worth $494,000 after buying an additional 18 shares during the period. LVW Advisors LLC grew its holdings in Intuitive Surgical by 1.3% during the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider's stock worth $756,000 after acquiring an additional 19 shares in the last quarter. Wesbanco Bank Inc. raised its holdings in shares of Intuitive Surgical by 1.6% during the fourth quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider's stock worth $635,000 after purchasing an additional 19 shares during the period. Finally, Journey Strategic Wealth LLC boosted its holdings in shares of Intuitive Surgical by 1.9% during the fourth quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider's stock valued at $542,000 after acquiring an additional 19 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Intuitive Surgical

In other news, EVP Gary Loeb sold 1,700 shares of the firm's stock in a transaction dated Friday, April 25th. The shares were sold at an average price of $513.18, for a total value of $872,406.00. Following the completion of the sale, the executive vice president now directly owns 2,245 shares of the company's stock, valued at approximately $1,152,089.10. This trade represents a 43.09 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the transaction, the director now owns 12,275 shares of the company's stock, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 35,454 shares of company stock worth $18,564,027. 0.70% of the stock is owned by corporate insiders.

Intuitive Surgical Trading Up 1.3 %

NASDAQ ISRG traded up $6.46 on Friday, hitting $514.59. 2,015,889 shares of the company were exchanged, compared to its average volume of 1,617,024. Intuitive Surgical, Inc. has a 12 month low of $367.39 and a 12 month high of $616.00. The stock has a fifty day moving average of $511.92 and a 200-day moving average of $533.05. The company has a market cap of $183.29 billion, a PE ratio of 80.28, a PEG ratio of 5.85 and a beta of 1.55.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The company had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. During the same period last year, the firm earned $1.50 earnings per share. On average, analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analyst Ratings Changes

A number of brokerages have recently commented on ISRG. Erste Group Bank downgraded Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research report on Monday, March 17th. JPMorgan Chase & Co. lifted their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an "overweight" rating in a research note on Friday, January 24th. Raymond James upped their target price on Intuitive Surgical from $560.00 to $688.00 and gave the stock an "outperform" rating in a research report on Friday, January 24th. Barclays dropped their price objective on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a research note on Thursday. Finally, Evercore ISI decreased their price target on shares of Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating on the stock in a research report on Wednesday. Five investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company's stock. Based on data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and a consensus target price of $598.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.